Skip to main content
Download PDF

Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

Trials volume 21, Article number: 556 (2020) Cite this article

The Original Article was published on 03 June 2020

Correction to: Trials (2020) 21:468

https://doi.org/10.1186/s13063-020-04453-5

Following publication of the original article [1], we have been notified that an initial was missed from one of the author names.

Originally published author names:

  • Bart Lambrecht

Correct author names:

  • Bart N. Lambrecht

The original article has been corrected.

Reference

  1. Maes, et al. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21:468. https://doi.org/10.1186/s13063-020-04453-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. Bastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, Jozefien Declercq and Karel Van Damme are joint first authors.

Authors and Affiliations

  1. VIB-UGent Inflammatie-researchcentrum, Oost-Vlaanderen, Ghent, Belgium

    Bastiaan Maes, Cedric Bosteels, Elisabeth De Leeuw, Jozefien Declercq, Karel Van Damme, Anja Delporte, Bénédicte Demeyere, Stéfanie Vermeersch, Marnik Vuylsteke, Joren Willaert, Laura Bollé, Yuri Vanbiervliet, Jana Decuypere, Frederick Libeer, Stefaan Vandecasteele, Isabelle Peene & Bart N. Lambrecht

Authors
  1. Bastiaan Maes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Cedric Bosteels
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisabeth De Leeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jozefien Declercq
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Karel Van Damme
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anja Delporte
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bénédicte Demeyere
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Stéfanie Vermeersch
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Marnik Vuylsteke
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joren Willaert
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Laura Bollé
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yuri Vanbiervliet
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Jana Decuypere
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Frederick Libeer
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Stefaan Vandecasteele
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Isabelle Peene
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Bart N. Lambrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bastiaan Maes.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maes, B., Bosteels, C., De Leeuw, E. et al. Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials 21, 556 (2020). https://doi.org/10.1186/s13063-020-04519-4

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13063-020-04519-4

Trials

ISSN: 1745-6215